Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page shows new related topics like 'Rheumatoid arthritis' and 'MedlinePlus Genetics' and adds a 'Revision: v3.6.6' label. These updates appear to reflect navigation and versioning metadata rather than changes to the study data.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page adds a 2015 U.S. NIH Grant/Contract funding line and removes related-topic entries including Rheumatoid arthritis and MedlinePlus Genetics from the related topics section, altering funding disclosure and topic associations.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.6.5 replaces the previous v3.6.4. This reflects a minor system update to the page.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page adds related topic links for rheumatoid arthritis and MedlinePlus Genetics, connecting the study to broader background information on the condition and genetics.SummaryDifference0.1%

- Check52 days agoChange DetectedThe revision stamp on the page was updated from v3.6.3 to v3.6.4, indicating a small internal update to the page's documentation/versioning. This update does not affect visible content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page no longer displays the Disease tag 'Rheumatoid arthritis' and the related topics section, including the MedlinePlus Genetics link. This changes how users navigate to disease-related topics but does not alter the study details presented.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.